Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
Rev Assoc Med Bras (1992)
.
2024 Aug 16;70(8):e20240322.
doi: 10.1590/1806-9282.20240322.
eCollection 2024.
Authors
Mohammad Amin Akbarzadeh
1
,
Yosra Vaez-Gharamaleki
2
,
Farid Jahanshahlou
3
,
Alireza Ghaffari Bavil
4
,
Sina Hamzehzadeh
5
6
,
Sina Seifimansour
7
,
Alireza Rahimi-Mamaghani
8
,
Mohammad-Salar Hosseini
1
2
3
8
Affiliations
1
Tabriz University of Medical Sciences, Research Center for Evidence-Based Medicine, Iranian EBM Center: A JBI Center of Excellence - Tabriz, Iran.
2
Tabriz University of Medical Sciences, Hematology and Oncology Research Center - Tabriz, Iran.
3
Tabriz University of Medical Sciences, Aging Research Institute, Research Center for Integrative Medicine in Aging - Tabriz, Iran.
4
Tabriz University of Medical Sciences, School of Medicine, Department of Internal Medicine - Tabriz, Iran.
5
Tabriz University of Medical Sciences, Medical Philosophy and History Research Center - Tabriz, Iran.
6
Tabriz University of Medical Sciences, Liver and Gastrointestinal Diseases Research Center - Tabriz, Iran.
7
Ardabil University of Medical Sciences, School of Medicine, Student Research Committee - Ardabil, Iran.
8
Tabriz University of Medical Sciences, Clinical Research Development Unit of Tabriz Valiasr Hospital - Tabriz, Iran.
PMID:
39166680
PMCID:
PMC11329259
DOI:
10.1590/1806-9282.20240322
No abstract available
Publication types
Systematic Review
Meta-Analysis
MeSH terms
COVID-19* / complications
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / complications
SARS-CoV-2*